CNETS NEWS

Caring Virtually: A Virtual Care Oncology Patient Study

June 30th, 2022|Comments Off on Caring Virtually: A Virtual Care Oncology Patient Study

I am writing to you as the co-Principal Investigator on CaringVirtually, a virtual care oncology patient study, requesting your support in sharing information about this study with your patient community and anyone else you [...]

CNETS Board Member Awareness

November 4th, 2021|Comments Off on CNETS Board Member Awareness

CNETS Board Member Awareness Patient Education and Fundraising A core function of CNETS is to offer the Canadian neuroendocrine cancer community useful, impactful and informative educational resources [...]

Les Cancers Endocriniens, published in Le Médecin du Québec

October 25th, 2021|Comments Off on Les Cancers Endocriniens, published in Le Médecin du Québec

Les Cancers Endocriniens, published in Le Médecin du Québec, October 2021 Dre. Cynthia Landry is a primary care physician in Châteauguay, Quebec, working as an emergency physician at the Anna-Laberge hospital. Dre. [...]

From Gallstones to Cancer: A Mother’s Journey with NETs

September 11th, 2021|Comments Off on From Gallstones to Cancer: A Mother’s Journey with NETs

Our amazing Hamilton/Halton/Niagara NET Support Group Leader, Vannesa Mann, shares her inspirational story! Zoomer | September 10th, 2021 For people with neuroendocrine tumours, early diagnosis and timely access to approved treatments can [...]

Pewter Zebra Keyfobs/Pendants

August 23rd, 2021|Comments Off on Pewter Zebra Keyfobs/Pendants

Volunteers create one-of-a-kind handmade Pewter Zebra Keyfobs/Pendants to help raise awareness & funds for CNETS Al Gillis is a neuroendocrine cancer patient and member of the Toronto Patient and Caregiver support group. One of [...]

Temozolomide Access in Ontario

July 6th, 2021|Comments Off on Temozolomide Access in Ontario

CNETS is pleased to share the news that the oral chemotherapy drug, temozolomide, often used in combination with capecitabine, known as the CAPTEM regimen, is now more accessible to Ontario-based neuroendocrine tumour (NET) patients.  [...]

Lutathera Funded in Saskatchewan

July 6th, 2021|Comments Off on Lutathera Funded in Saskatchewan

As of June 1, 2021, Lutathera is now available in Saskatchewan. The reimbursement criteria is for patients with unresectable, well-differentiated midgut* neuroendocrine tumors (NET) in patients who have experienced radiographic disease progression during somatostatin [...]

How a better image can save a life

April 25th, 2021|Comments Off on How a better image can save a life

The Globe and Mail: How a better image can save a life Sharon Needham, with oncologist Dr. Daniel Rayson, and radiologist Dr. Steven Burrell, at the QEII Health Sciences Centre [...]